WASHINGTON (AP) — Roger Clemens' second perjury trial began Monday, following a mistrial in the first case when prosecutors showed inadmissible evidence to the jury.
The famed former pitcher is accused of lying to Congress in 2008 when he said he never used performance-enhancing drugs.
The new trial, which begins with jury selection, is expected to last four to six weeks.
Some key data and figures in the case:
Three counts of making false statements, two counts of perjury and one count of obstruction of Congress.
If convicted on all counts, Clemens could face up to 30 years in prison and a $1.5 million fine. But with no prior criminal record, under U.S. sentencing guidelines, he would probably face no more than 15 to 21 months in prison.
Former baseball stars Barry Bonds and Jose Canseco were on the list of 104 potential witnesses or people who might be mentioned at trial that was read to the jury pool. In addition to Bonds and Canseco, prosecutors said they might call baseball commissioner Bud Selig and New York Yankees general manager Brian Cashman. Clemens' attorneys said they might call his former teammates Paul O'Neill, Jorge Posada and Mike Stanton and baseball writer Peter Gammons.
Potential jurors answered yes or no to 86 screening questions posed by U.S. District Judge Reggie Walton. Among them: "Do you have any opinions about Major League Baseball — good, bad or whatever?"
By the end of the first day, only 13 of the 90 potential jurors had been screened for possible prejudice or schedule conflicts and just seven had been asked to return Wednesday for more screening. The day's tedious pace prompted Walton to chide the lawyers: "It doesn't help the process to repeat what I've already asked."
In addition to people disqualified by the judge for cause, the defense will be allowed reject 10 potential jurors and the prosecutors can veto six — without explanation — until 12 are seated. Then each side will get two such unexplained strikes until four alternates are chosen, in case any jurors have to drop out during the trial.